SMTL ID : 5my6.1

Crystal structure of a HER2-Nb complex

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.25 Å

Oligo State

hetero-1-1-mer

Ligands

1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-NAG.1: 5 residues within 4Å: Chain A: C.229, A.231, C.232, N.236, G.239 1 PLIP interactions: 1 interactions with chain A Water bridges: A:R.77

1 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.2: 1 residues within 4Å: Chain A: N.164 No protein-ligand interaction detected (PLIP)

2 x GOL: GLYCEROL(Non-functional Binders)

GOL.3: 7 residues within 4Å: Chain A: Y.140, T.143, R.165, C.169, H.170, P.171, C.172 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:C.172 GOL.4: 5 residues within 4Å: Chain A: E.381, E.382, Q.406, V.407, R.436 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:R.436

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

D'Huyvetter, M. et al., (131)I-labeled Anti-HER2 Camelid sdAb as a Theranostic Tool in Cancer Treatment. Clin. Cancer Res. (2017)

Release Date

2017-08-09

Peptides

Receptor tyrosine-protein kinase erbB-2: A
Nanobody 2Rs15d: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Receptor tyrosine-protein kinase erbB-2

Nanobody 2Rs15d